News for Revolve Group, Inc. (RVLV)

Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q1 2025, optimism fueled by the Trump election shifted to fear and uncertainty due to apprehension about cost-cutting measures and emerging trade policies. In the first quarter, […]

The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a correction in 1Q25 due to macro risks, weak economic growth, and inflation. The fund declined 6.9% (-7.1%, net) compared to a 9.5% decrease […]

Roth Capital has revised its price target for Revolve Group (RVLV), reducing it from $25 to $19, while maintaining a Buy rating on the stock. The agency pointed

Raymond James has reduced its price target for Revolve Group (RVLV), adjusting it from $25 to $21, while maintaining an Outperform rating on the stock. The adju

Baird analyst Mark Altschwager has adjusted the price target for Revolve Group (RVLV), reducing it from $25 to $23. Despite maintaining a Neutral stance on the

An analyst from BofA, Lorraine Hutchinson, has reduced the price target for Revolve Group (RVLV) from $25 to $20, maintaining an underperform rating on its shar

UBS has revised its price target for Revolve Group (RVLV), decreasing it from $22 to $19 while maintaining a Neutral rating on the stock. Despite the company's

U.S. stock futures were higher this morning, with the Dow futures gaining over 300 points on Wednesday. Shares of Sarepta Therapeutics, Inc. SRPT fell sharply ...

KeyBanc has revised its price target for Revolve Group (RVLV), trimming it from $37 to $25 while maintaining an Overweight rating on the stock. The adjustment c

Barclays analyst Trevor Young has revised the price target for Revolve Group (RVLV), lowering it to $17 from a previous $26, while maintaining an Equal Weight r

Shares of Porch Group, Inc. PRCH rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and ...

Revolve Group, Inc. (NYSE:RVLV) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ETCompany ParticipantsErik Randerson - Vice President-Investor...

PR NewswireLOS ANGELES, May 6, 2025 LOS ANGELES, May 6, 2025 /PRNewswire/ -- Revolve Group, Inc. (NYSE: RVLV), the next-generation fashion retailer for Mil

Revenue: $296.7 million, slightly below the estimated $298.03 million, but up 10% year-over-year.Earnings Per Share (EPS): $0.16, surpassing the estimated $0.1

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click for my updated look at HIMS stock.

On May 1, 2025, Baird analyst Mark Altschwager released an update on Revolve Group (RVLV), maintaining a 'Neutral' rating on the stock. Despite maintaining the

Analyst Mark Altschwager from Baird has revised the price target for Revolve Group (RVLV), decreasing it from $26 to $25. Despite this adjustment, the analyst m

On March 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Revolve Group Inc. The firm reduced its holdings by 1,155,07

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a game-changing deal for HIMS stock.